These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC. Jondreville L; D'Aveni M; Labussière-Wallet H; Le Bourgeois A; Villate A; Berceanu A; Bezsera SM; Thiebaut A; Boissard-Simonet M; Legrand M; Cornillon J; Rubio MT; Chevallier P; Nguyen S J Hematol Oncol; 2022 Nov; 15(1):169. PubMed ID: 36443846 [TBL] [Abstract][Full Text] [Related]
18. [Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies]. Roppelt AA; Lebedkina MS; Chernov AA; Kruglova TS; Mukhina OA; Yukhnovskaya YD; Samedova FA; Mаrkina UA; Andrenova GV; Karaulov AV; Lysenko MA; Fomina DS Ter Arkh; 2023 Feb; 95(1):78-84. PubMed ID: 37167118 [TBL] [Abstract][Full Text] [Related]
20. Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak. You J; Tian J; Wu H; Kang W; Wen J; Xu H; Shi W; Wang Z; Wei H; Du Y; Li X; Mu G; Zhou M; Gu Z; Qu J Expert Rev Anti Infect Ther; 2023; 21(12):1365-1371. PubMed ID: 37855094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]